CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 6 enrolled
Drug / intervention
Insulin LISPRO intravenous loadingdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02962921
NCT02962921Phase 4Completed

Acute Insulin Effects on Cardiac Function in Patients With Diabetes Mellitus

Rambam Health Care Campus·interventional·Posted Nov 15, 2016·Updated Nov 15, 2016

In Brief

A Phase 4 clinical trial evaluating Insulin LISPRO intravenous loading for Diabetes Mellitus and Ventricular Dysfunction. Completed, enrolled 6 participants across 1 site.

Detailed Summary

Our investigation studies the role of acute insulin administration on the diabetic heart, its corresponding effective blood-insulin level and the time-course applicability of insulin in a routine clinical setting. A case series of six male (48.1 ± 4.9 y/o) patients with controlled diabetes (HbA1c of 6.6 ± 0.3%, disease duration of 14.4 ± 6.7 yr). Each subject was evaluated for glucose homeostatic, hemodynamic and echocardiographic systolic and diastolic parameters at baseline and following two successive insulin-load steps of a euglycemic hyperinsulinemic clamp study, each 2 h in duration. Results are presented as a mean ± SEM and analysed using the student's t-test.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesIsrael
Collaborators--

Timeline

Phase 4CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 15, 2016
Enrollment StartFeb 1, 2003
Primary CompletionMay 1, 2003
Study CompletionNov 1, 2004
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 9.6 years ago

Interventions

Insulin LISPRO intravenous loadingdrug

intravenous infusion of insulin Lispro.